Logo

J B Chemicals and Pharmaceuticals Share Price

NSE: JBCHEPHARM
|
Pharmaceuticals
₹ 2,364.60
+₹43.40 (1.87%)
1D
Last updated 03 Jul, 2026, 15:48 IST

J B Chemicals and Pharmaceuticals Share Price Today

As of 5 Jul 2026, J B Chemicals and Pharmaceuticals share price is ₹2,364.60. The stock opened at ₹2,328.00, compared to its previous close of ₹2,321.20. During today's trading session, J B Chemicals and Pharmaceuticals share price moved in the range of ₹2,327.90 to ₹2,371.80, with an average price of ₹2,349.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,603.50 and a high of ₹2,371.80. On the performance front, J B Chemicals and Pharmaceuticals share price has increased by 27.79% over the last six months and is up 44.24% on a year-on-year basis.

₹2,327.90
1.87% up today
₹2,371.80
1D LOW
1D HIGH

J B Chemicals and Pharmaceuticals Returns Calculator

Open
₹2,328.00
High
₹2,371.80
Low
₹2,327.90
Prev. close
₹2,321.20
Circuit
L
H
₹1,891.70
₹2,837.50
52-week
L
H
₹1,603.50
₹2,371.80

J B Chemicals and Pharmaceuticals Shareholder Returns

J B Chemicals and Pharmaceuticals Share Price History

Mkt Cap Cr
37,224.70
P/E
46.69
P/B
7.96
ROE
18.69%
D/E
0.00
ROCE
24.94%
Div. Yield
1.07%
EPS(TTM)
42.91
Turnover
0.91
EV/EBITDA
28.92
Net Margin
17.33%
Op. Margin
27.87%
ROA
16.91%
Quick Ratio
3.70
Curr. Ratio
2.22
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
J B Chemicals & outperforming all market indices
Step 1 of 5
Valuation
Overvalued
J B Chemicals & appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
J B Chemicals & earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

J B Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,147.79₹3,917.99₹3,484.18₹3,149.28
Other Income₹60.15₹38.32₹37.27₹9.94
Total Revenue₹4,207.94₹3,956.31₹3,521.45₹3,159.22
Total Expenses₹3,228.42₹3,068.92₹2,769.94₹2,603.99
Profit Before Tax₹952.34₹887.39₹751.51₹555.23
Tax₹242.86₹227.81₹198.88₹145.23
Profit After Tax₹709.47₹659.58₹552.63₹410.01
EPS - Basic₹45.16₹42.45₹35.66₹53.00
EPS - Diluted₹44.45₹41.56₹34.85₹52.34

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹952.34₹887.39₹751.51₹555.23
Income before WC changes₹1,191.46₹1,095.95₹938.73₹751.01
Change in Assets-₹211.03-₹76.24-₹143.63-₹62.27
Change in Liabilities-₹20.27₹83.42₹138.00₹32.35
Change in WC-₹231.30₹7.17-₹5.64-₹29.92
Cash flow from Operations₹703.92₹902.45₹800.61₹625.61
Cash flow from Investing-₹585.88-₹295.90-₹403.83-₹961.79
Cash flow from Financing-₹123.10-₹579.67-₹385.49₹356.54
Total Cash Flow-₹5.05₹26.88₹11.30₹20.36
Cash (Start of the year)₹115.09₹88.22₹76.93₹56.54
Cash (End of the year)₹110.18₹115.09₹88.22₹76.93

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,059.27₹2,351.04₹2,140.78₹2,025.84
Current Assets₹2,909.37₹1,922.74₹1,853.35₹1,528.03
Total Assets₹4,968.65₹4,273.78₹3,994.13₹3,553.87
Current Liabilities₹591.16₹632.34₹868.23₹554.45
Net Current Asset₹2,318.21₹1,290.40₹985.12₹973.58
Non-Current Liabilities₹218.26₹208.13₹202.57₹519.07
Equity Capital₹4,159.22₹3,433.32₹2,923.33₹2,480.35
Total Equity & Liabilities₹4,968.65₹4,273.78₹3,994.13₹3,553.87

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,889.89₹3,722.92₹3,298.64₹2,884.16
Other Income₹55.28₹34.74₹34.67₹8.65
Total Revenue₹3,945.17₹3,757.66₹3,333.32₹2,892.81
Total Expenses₹3,015.26₹2,880.56₹2,594.98₹2,365.77
Profit Before Tax₹902.73₹877.11₹738.34₹527.04
Tax₹228.63₹224.56₹194.98₹138.15
Profit After Tax₹674.10₹652.54₹543.36₹388.89
EPS - Basic₹42.91₹42.00₹35.07₹50.29
EPS - Diluted₹42.23₹41.16₹34.30₹49.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹902.73₹877.11₹738.34₹527.04
Income before WC changes₹1,111.93₹1,071.17₹925.60₹729.85
Change in Assets-₹204.76-₹76.58-₹140.93-₹56.66
Change in Liabilities-₹16.19₹82.28₹132.29₹44.04
Change in WC-₹220.94₹5.70-₹8.64-₹12.62
Cash flow from Operations₹644.89₹884.03₹789.03₹628.64
Cash flow from Investing-₹587.21-₹289.93-₹412.45-₹955.88
Cash flow from Financing-₹107.68-₹574.27-₹374.08₹343.41
Total Cash Flow-₹50.00₹19.84₹2.50₹16.17
Cash (Start of the year)₹76.21₹56.37₹53.88₹37.69
Cash (End of the year)₹26.36₹76.21₹56.37₹53.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,106.18₹2,399.24₹2,198.24₹2,071.85
Current Assets₹2,717.32₹1,778.65₹1,715.40₹1,398.30
Total Assets₹4,823.50₹4,177.90₹3,913.64₹3,470.15
Current Liabilities₹560.91₹584.44₹821.06₹508.03
Net Current Asset₹2,156.41₹1,194.22₹894.34₹890.27
Non-Current Liabilities₹224.88₹216.26₹206.32₹519.64
Equity Capital₹4,037.71₹3,377.19₹2,886.26₹2,442.48
Total Equity & Liabilities₹4,823.50₹4,177.90₹3,913.64₹3,470.15
* All values are in INR Crore
Qty
Bid
19
2364.6
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 19
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
74.73
Bullish
ATR (14)
48.11
Neutral
STOCH(9,6)
96.55
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
37.6
Bearish
UO(9)
62.51
Neutral
ROC(12)
7.83
Bullish
WillR(14)
-3.45
Bearish
Period
Simple value
Exponential vaue
5D
2316.58
2316.29
10D
2269.65
2284.33
20D
2238.27
2247.33
50D
2169
2179.3
100D
2092.94
2096.85

About J B Chemicals and Pharmaceuticals

J B Chemicals and Pharmaceuticals logo
ISIN
INE572A01036
Sector Market Cap
₹ 37,224.7 Cr

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.

J B Chemicals and Pharmaceuticals Financial Highlights

  • Revenue: J B Chemicals and Pharmaceuticals reported revenue of ₹4,207.94 crore in FY26 vs ₹3,956.31 crore in FY25. It showed an increase of 6.36% on a yearly basis.
  • Operating Profit: J B Chemicals and Pharmaceuticals reported an operating profit of ₹952.33 crore in FY26 vs ₹887.39 crore in FY25. It showed an increase of 7.32% on a year-on-year basis.
  • Net Profit: J B Chemicals and Pharmaceuticals reported a net profit of ₹709.47 crore in FY26 vs ₹659.58 crore in FY25. It showed an increase of 7.56% on a yearly basis.

J B Chemicals and Pharmaceuticals Quarterly Result Highlights

  • J B Chemicals and Pharmaceuticals reported revenue of ₹916.21 crore in Mar 2026, compared with ₹1,083.00 crore in Dec 2025, representing a decrease of 15.40% on a quarter-on-quarter (QoQ) basis.
  • J B Chemicals and Pharmaceuticals reported an operating profit of ₹134.69 crore in Mar 2026, compared with ₹266.87 crore in Dec 2025, representing a decrease of 49.53% on a quarter-on-quarter (QoQ) basis.
  • J B Chemicals and Pharmaceuticals reported a profit of ₹101.37 crore in Mar 2026, compared with ₹197.89 crore in Dec 2025, reflecting a decrease of 48.77% on a QoQ basis.
  • The earnings per share (EPS) of J B Chemicals and Pharmaceuticals stood at ₹45.16 during Mar 2026.
Know more
Promoters
48.80%
FII
16.33%
Other DII
2.39%
Retail and other
13.48%
Mutual funds
19.00%
Foreign institutions - FII
Compare against other stocks
J B Chemicals and Pharmaceuticals logo
J B Chemicals and Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

FAQs on J B Chemicals and Pharmaceuticals Share Price